Inbibition by a putative antipsychotic quinolinone derivative (OPC-14597) of dopaminergic neurons in the ventral tegmental area

European Journal of Pharmacology

Volumn 310, Issue 1, 1996, Pages 1-8

  Momiyama, Toshihiko ^a   Amano, Taku ^b   Todo, Naoyuki ^a   Sasa, Masashi ^b  

^a KYOTO UNIVERSITY   (Japan)

^b HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Dopamine D2 receptor; Extracellular recording in vivo; OPC 14597; Thin slice preparation; Ventral tegmental area; Whole cell recording

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOMPERIDONE; DOPAMINE RECEPTOR STIMULATING AGENT; NEUROLEPTIC AGENT; ARIPIPRAZOLE; DOPAMINE RECEPTOR BLOCKING AGENT; PIPERAZINE DERIVATIVE; QUINOLONE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; HYPERPOLARIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICROELECTROPHORESIS; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT; VENTRAL TEGMENTUM; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; IN VITRO STUDY; WISTAR RAT;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; ANTIPSYCHOTIC AGENTS; DOMPERIDONE; DOPAMINE ANTAGONISTS; MALE; PIPERAZINES; QUINOLONES; RATS; RATS, WISTAR; VENTRAL TEGMENTAL AREA;

EID: 0030598104     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00350-0     Document Type: Article

References (36)

1. Ackerman, J.M., P.A. Johansen, D. Clark and F.J. White, 1993, Electrophysiological effects of putative autoreceptor-selective dopamine agonists on A10 dopamine neurons, J. Pharmacol. Exp. Ther. 265, 963.
2. Amano, T., H. Matsubayashi, T. Momiyama, K. Ishihara, N. Todo and M. Sasa, 1995, Antagonizing effects of a novel antipsychotic quinolinone derivative (OPC-14597) on dopaminergic inhibition of neuronal activities in the nucleus accumbens, Prog. Neuro-psychopharmacol. Biol. Psychiat. 19, 105.
3. Bunney, B.S., J.R. Walters, R.H. Roth and G.K. Aghajanian, 1973, Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity, J. Pharmacol. Exp. Ther. 185, 560.
4. Chiodo, L.A. and B.S. Bunney, 1983, Electrophysiological studies on EMD 23448, an indolyl-3-butylamine, in the rat: a putative selective dopamine autoreceptor agonist, Neuropharmacol. 22, 1087.
5. Clark, D., G. Engberg, E. Pileblad, T.H. Svensson, A. Carlson, A.S. Freeman and B.S. Bunney, 1985, An electrophysiological analysis of the actions of the 3-PPP enantiomers on the nigrostriatal dopamine system, Naunyn-Schmiedebergs Arch. Pharmacol. 329, 344.
6. Cox, R.F. and B.L. Waszczak, 1989, Differences in dopamine receptor reserve for N-n-propylnorapomorphine enantiomers: single unit recording studies after partial inactivation of receptors by N-ethoxy-carbonyl-2-ethoxy-1,2-dihydroquinoline, Mol. Pharmacol. 35, 125.
7. Edwards, F.A., A. Konnerth, B. Sakmann and T. Takahashi, 1989, A thin-slice preparation for patch clamp recordings from neurons of the mammalian central nervous system, Pflügers Arch. 414, 600.
8. Enz, A., M. Goldstein and E. Meller, 1990, Dopamine agonist-induced elevation of striatal acetylcholine: relationship between receptor occupancy an response in normal and denervated rat striatum, Mol. Pharmacol. 37, 560.
9. Grace, A.A. and B.S. Bunney, 1980, Nigral dopamine neurons: intracellular recording and identification with L-dopa injection and histofluorescence, Science 210, 654.
10. Grace, A.A. and S.P. Onn, 1989, Morphology and electrophysiological properties of immunocytochemically identified rat dopamine neurons recorded in vitro, J. Neurosci. 9, 3463.
11. Johnson, S.W. and R.A. North, 1992, Two types of neuron in the rat ventral tegmental area and their synaptic inputs, J. Physiol. 450, 455.
12. Kikuchi, T., K. Tottori, Y. Uwahodo, T. Hirose, T. Miwa, Y. Oshiro and S. Morita, 1995, 7-{4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butyloxy}-3,4-dihydro-2(1H)-q uinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity, J. Pharmacol. Exp. Ther. 274, 329.
13. 2 receptor, on tyrosine hydroxylation in rat striatal slices, Life Sci. 42, 343.
14. 2 receptors to increase potassium conductance in neurons of the substantia nigra zona compacta, J. Physiol. 392, 397.
15. Lacey, M.G., N.B. Mercuri and R.A. North, 1990, Actions of cocaine on rat dopaminergic neurons in vitro, Br. J. Pharmacol. 99, 731.
16. Matsubayashi, H., T. Amano, Y. Honging, Y. Kohno and M. Sasa, 1995, Action of intravenously administered talipexole on the rat striatal neurons receiving excitatory input from nigral dopamine neurons, Psychopharmacology 120, 369.
17. Meller, E., E. Helmer-Matyjec, K. Bohmaker, C.H. Adler, A.J. Friedhoff and M. Goldstein, 1986, Receptor reserve at striatal dopamine autoreceptors: implications for selectivity of dopamine agonists, Eur. J. Pharmacol. 123, 311.
18. Meller, E., K. Bohmaker, Y. Namba, A.J. Friedhoff and M. Goldstein, 1987, Relationship between receptor occupancy and responses at striatal dopamine autoreceptors, Mol. Pharmacol. 31, 592.
19. Meltzer, L.T., C.L. Christoffersen, A.E. Corbin, F.W. Ninteman, K.A. Serpa, J.N. Wiley, L.D. Wise and T.G. Heffner, 1995, CI-1007, a dopamine partial agonist and potential antipsychotic agent. II. neurophysiological and behavioral effects, J. Pharmacol. Exp. Ther. 274, 912.
20. Momiyama, T., M. Sasa and S. Takaori, 1990, D-2 receptor-mediated inhibition by a substituted quinolinone derivative, 7-{3-[4-(2,3-dimethylphenyl)piperazinyl]propoxy}-2(1H)-quinolinone (OPC-4392), of dopaminergic neurons in the ventral tegmental area, Life Sci. 47, 761.
21. Momiyama, T., M. Sasa and S. Takaori, 1991, Inhibition by talipexole, a thiazolo-azepine derivative, of dopaminergic neurons in the ventral tegmental area, Life Sci. 49, 535.
22. 2 receptor-mediated inhibition of dopaminergic neurons in the ventral tegmental area in vitro, Br. J. Pharmacol. 109, 933.
23. 1 receptor agonist in the ventral tegmental area, Br. J. Pharmacol. 110, 713.
24. Mueller, A.L. and M.S. Brodie, 1989, Intracellular recording from putative dopamine-containing neurons in the ventral tegmental area of Tsai in a brain slice preparation, J. Neurosci. Methods 28, 15.
25. 2 agonist, in the treatment of negative symptoms of chronic schizophrenia, Biol. Psychiat. 33, 687.
26. Paxinos, G. and C. Watson, 1986, The Rat Brain in Stereotaxic Coordinates, 2nd Ed., Academic Press, Sydney.
27. Roth, R.H., 1979, Dopamine autoreceptors: pharmacology, function and comparison with post-synaptic dopamine receptors, Commun. Psychopharmacol. 3, 429.
28. Sasa, M., Y. Ohno and S. Takaori, 1988, Presynaptic inhibition of excitatory input from the substantia nigra to caudate nucleus neurons by a substituted quinolinone derivative, 7-{3-[4-(2,3-dimethylphenyl)piperazinyl]propoxy}-2(1H)-quinolinone (OPC-4392), Life Sci. 43, 263.
29. Sibley, D.R., A.M. Gonzalez, L.H. Burgess, S.I. Max, B.N. Atkinson and L.-J. Zhang, 1994, Pharmacological characterization of OPC-14597, a novel antipsychotic agent, using cloned dopamine and serotonin receptors, Neuropsychopharmacology 10, Suppl. II, 252S.
30. 2 receptor, Eur. J. Pharmacol. 225, 331.
31. Takahashi, T., 1990, Membrane currents in visually identified motoneurons, J. Physiol. 423, 27.
32. 2 agonist, of caudate nucleus neurons activated by nigral stimulation, Life Sci. 54, 957.
33. Wang, R.Y., 1981, Dopaminergic neurons in the ventral tegmental area. I. Identification and characterization, Brain Res. Rev. 3, 123.
34. White, F.J. and R.Y. Wang, 1984a, A 10 dopamine neurons: role of autoreceptors in determining firing rate and sensitivity to dopamine agonists, Life Sci. 34, 1161.
35. White, F.J. and R.Y. Wang, 1984b, Pharmacological characterization of dopamine autoreceptors in the rat ventral tegmental area: microiontophoretic studies, J. Pharmacol. Exp. Ther. 231, 275.
36. 2 receptor antagonist, Life Sci. 42, 1941.